Live bacterial delivery systems for development of mucosal vaccines.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Current opinion in molecular therapeutics (Print)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11249657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a ΔglnA Balanced Lethal Plasmid System for Expression of Heterologous Antigens by Attenuated Vaccine Vector Strains of Vibrio cholerae

  2000cited by this paper
• Gene expression systems for lactic acid bacteria.

  1999cited by this paper
• Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.

  1999cited by this paper
• The expression signals of the Lactobacillus brevis slpA gene direct efficient heterologous protein production in lactic acid bacteria

  1999cited by this paper
• Live attenuated Salmonella: a paradigm of mucosal vaccines

  1999cited by this paper
• Regional specialization in the mucosal immune system: primed cells do not always home along the same track.

  1999cited by this paper
• Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes

  1999cited by this paper
• Microbial-host interactions at mucosal sites. Host response to pathogenic bacteria at mucosal sites.

  1999cited by this paper
• Antigenicity and Immunogenicity of the V3 Domain of HIV Type 1 Glycoprotein 120 Expressed on the Surface of Streptococcus gordonii

  1999cited by this paper
• Cell Wall-Anchored CshA Polypeptide (259 Kilodaltons) in Streptococcus gordonii Forms Surface Fibrils That Confer Hydrophobic and Adhesive Properties

  1999cited by this paper
• Bacterial mucosal vaccines: Vibrio cholerae as a live attenuated vaccine/vector paradigm.

  1999cited by this paper
• Microbial-Host Interactions at Mucosal Sites. Host Response to Pathogenic Bacteria at Mucosal Sites

  1999cited by this paper
• Recombinant Staphylococcus Strains as Live Vectors for the Induction of Neutralizing Anti-Diphtheria Toxin Antisera

  1999cited by this paper
• Use of In Vivo-Regulated Promoters To Deliver Antigens from Attenuated Salmonella enterica var. Typhimurium

  1999cited by this paper
• A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery.

  1999cited by this paper
• Salmonella vaccine carrier strains: effective delivery system to trigger anti‐tumor immunity by oral route

  1999cited by this paper
• Surface display of functional fibronectin‐binding domains on Staphylococcus carnosus

  1999cited by this paper
• Secretion of Functional Salivary Peptide by Streptococcus gordonii Which Inhibits Fimbria-Mediated Adhesion ofPorphyromonas gingivalis

  1999cited by this paper
• Surface Expression of a Protective Recombinant Pertussis Toxin S1 Subunit Fragment in Streptococcus gordonii

  1999cited by this paper
• Pathogenicity Island 2 Mutants of Salmonella typhimurium Are Efficient Carriers for Heterologous Antigens and Enable Modulation of Immune Responses

  1999cited by this paper
• Heterologous protein secretion in Lactococcus lactis: a novel antigen delivery system.

  1999cited by this paper
• Immunogenicity of a Salmonella typhimurium aroA aroD Vaccine Expressing a Nontoxic Domain of Clostridium difficile Toxin A

  1999cited by this paper
• Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats

  1999cited by this paper
• Persistence and Protective Efficacy of aMycobacterium tuberculosis Auxotroph Vaccine

  1999cited by this paper
• Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax.

  1999cited by this paper
• In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae

  1999cited by this paper
• Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL‐12 production

  1999cited by this paper
• The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases.

  1999cited by this paper
• Engineering of a Staphylococcus carnosus surface display system by substitution or deletion of a Staphylococcus hyicus lipase propeptide.

  1999cited by this paper
• Expression of Recombinant EnterotoxigenicEscherichia coli Colonization Factor Antigen I bySalmonella typhimurium Elicits a Biphasic T Helper Cell Response

  1999cited by this paper
• Construction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin.

  1999cited by this paper
• Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.

  1999cited by this paper
• Mucosal immunity and tolerance: relevance to vaccine development

  1999cited by this paper
• Immune response to rotavirus VP4 expressed in an attenuated strain of Shigella flexneri.

  1999cited by this paper
• Oral Vaccination of White‐Tailed Deer Using a Recombinant Bacillus Calmette‐Guérin Vaccine Expressing the Borrelia burgdorferi Outer Surface Protein A: Prospects for Immunocontraception

  1999cited by this paper
• Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.

  1999cited by this paper
• Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis

  1998cited by this paper
• Mucosal Delivery of Murine Interleukin-2 (IL-2) and IL-6 by Recombinant Strains of Lactococcus lactis Coexpressing Antigen and Cytokine

  1998cited by this paper
• Interaction of Microorganisms, Epithelium, and Lymphoid Cells of the Mucosa‐Associated Lymphoid Tissue

  1998cited by this paper
• Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes.

  1998cited by this paper
• Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

  1997cited by this paper
• The genetic reconstruction of BCG as a new immunotherapeutic tool.

  1997cited by this paper

• Modern technologies for the production of vaccines against avian infectious diseases

  2021cites this paper
• Recombinant Probiotics and Microbiota Modulation as a Good Therapy for Diseases Related to the GIT

  2019cites this paper
• PilVax – a novel peptide delivery platform for the development of mucosal vaccines

  2018cites this paper
• A review of vaccine development and research for industry animals in Korea

  2012cites this paper
• Oral vaccination with attenuated Salmonella choleraesuis C500 expressing recombinant UreB and CagA antigens protects mice against Helicobacter pylori

  2012cites this paper
• Potential of auxotrophic Edwardsiella tarda double-knockout mutant as a delivery vector for DNA vaccine in olive flounder (Paralichthys olivaceus).

  2012cites this paper
• Development of mucosal vaccines for avian influenza A virus composed of recombinant Lactococcus lactis and Streptococcus gordonii

  2011cites this paper
• Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route

  2011cites this paper
• Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector.

  2010cites this paper
• Immune responses elicited in mice with recombinant Lactococcus lactis expressing F4 fimbrial adhesin FaeG by oral immunization

  2010cites this paper
• Salmonella Vaccines for Animals and Birds and Their Future Perspective

  2009cites this paper
• [Generation of mucosal vaccine utilizing lactobacillus display system].

  2009cites this paper
• Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B

  2009cites this paper
• Veterinary vaccines: alternatives to antibiotics?*

  2008cites this paper
• Oral immunization of broiler chickens against necrotic enteritis with an attenuated Salmonella vaccine vector expressing Clostridium perfringens antigens.

  2008cites this paper
• Display of heterologous proteins on the surface of Lactococcus lactis using the H and W domain of PrtB from Lactobacillus delburueckii subsp. bulgaricus as an anchoring matrix

  2008cites this paper
• Chapter 54 – Cancer-Specific Vaccines

  2008cites this paper
• Cross-talk between probiotic bacteria and the host immune system.

  2007cites this paper
• Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2.

  2007cites this paper
• Lactobacillus plantarum for oral peptide delivery.

  2007cites this paper
• Effects of Probiotics and Prebiotics Cross-Talk between Probiotic Bacteria and the Host Immune System 1 , 2

  2007cites this paper
• Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus.

  2007cites this paper
• Mucosal delivery of vaccines in domestic animals.

  2006cites this paper
• Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis

  2006cites this paper
• Micro-organismes probiotiques etrgulation immunologique: leparadoxe

  2006cites this paper
• Tumor Vaccination by Salmonella typhimurium After Transformation with a Eukaryotic Expression Vector in Mice: Impact of a Salmonella typhimurium Gene Interfering with MHC Class I Presentation

  2005cites this paper
• Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA.

  2005cites this paper
• Chapter 15 Development of lactobacilli for mucosal immunization

  2005cites this paper
• Mucosal Vaccine Made from Live, Recombinant Lactococcus lactis Protects Mice against Pharyngeal Infection with Streptococcus pyogenes

  2004cites this paper
• Study of Humoral Immunity to Commensal Oral Bacteria in Human Infants Demonstrates the Presence of Secretory Immunoglobulin A Antibodies Reactive with Actinomyces naeslundii Genospecies 1 and 2 Ribotypes

  2004cites this paper
• Potential and opportunities for use of recombinant lactic acid bacteria in human health.

  2004cites this paper
• New scientific paradigms for probiotics and prebiotics.

  2003cites this paper
• Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future

  2003cites this paper
• Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.

  2003cites this paper
• Controversies in BCG immunization

  2003cites this paper
• Induction of Partial Protection in Mice after Oral Administration of Lactococcus lactis Producing Brucella abortus L7/L12 Antigen

  2003cites this paper
• The Use of Live Attenuated Bacteria as a Delivery System for Heterologous Antigens

  2003cites this paper
• Gut-associated lactobacilli for oral immunisation

  2002cites this paper
• Engineered Commensal Bacteria as Delivery Systems of Anti-infective Mucosal Protectants

  2002cites this paper
• Vaccines: Spinning molecular immunology into successful immunotherapy

  2002cites this paper
• Probiotic microorganisms: how they affect intestinal pathophysiology

  2002cites this paper